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Abstract
Background: Sickle cell disease is the most frequent hereditary disease in Brazil, and people with
the disease may be hospitalised several times in the course of their lives. The purpose of this study
was to estimate the hazard ratios of factors associated with the time between hospital admissions.
Methods: The study sample comprised all patients admitted, from 2000 to 2004, to a university
hospital in Rio de Janeiro State, south-east Brazil, as a result of acute complications from sickle cell
disease (SCD). Considering the statistical problem of studying individuals with multiple events over
time, the following extensions of Cox's proportional hazard ratio model were compared: the
independent increment marginal model (Andersen-Gill) and the random effects model.
Results: The study considered 71 patients, who were admitted 223 times for acute events related
to SCD. The hazard ratios for hospital readmission were statistically significant for the prior
occurrence of vaso-occlusive crisis and development of renal failure. However, analysis of residuals
of the marginal model revealed evidence of non-proportionality for some covariates.
Conclusion: the results from applying the two models were generally similar, indicating that the
findings are not highly sensitive to different approaches. The better fit by the frailty model suggests
that there are unmeasured individual factors with impact on hospital readmission.
Background
In Brazil, sickle cell disease (SCD) is the most prevalent of
the hereditary diseases, particularly among Afro-descend-
ants. It is characterised by mutation of the beta globin
chain gene, producing an abnormal variant called haemo-
globin S (HbS) [1]. Abnormal haemoglobin can cause var-
ious clinical events, the most common being vaso-
occlusive crisis (VOC), characterised by acute episodes of
abdominal, thoracic and bone pain and chronic haemo-
lytic anaemia. These events, particularly VOC, require
hospital care [2,3].
The disease evolves very differently from patient to patient
and this variability seems to be related to hereditary and
environmental factors, including aspects of socio-eco-
nomic situation. While the disease progresses benignly
and even without symptoms in some patients, others are
more prone to complications, and a small subgroup has
high rates of VOC and requires multiple hospital admis-
sions [4]. Several studies estimate that high admission
rates are associated with worse prognosis and higher mor-
tality [5-7].
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Sickle cell disease causes premature death [8], particularly
in Brazil where, from 1996 to 2000, more than 60% of
deaths from the disease occurred in patients under 29
years old [9]. A North American study estimated that the
probability of death among 10 to 19 year olds with SCD
was 8 times higher than for the population of the same
age and race [5]. High number of symptoms is associated
with worse prognosis and early death. Patients with SCD
who undergo a large number of painful episodes are more
likely to die prematurely [8].
Hospital care generally has been an important object of
health service research, given its central role in care and
high costs. Knowledge of factors associated with hospital
service use is crucial to public policy-making to improve
these services in Brazil [10]. This approach should be
applied with the focus on specific diseases, especially
those in which patients need multiple hospital admis-
sions, as is the case with SCD. The purpose of this study is
to estimate the effect of factors associated with successive
hospitalisations of patients with SCD.
Methods
This is a retrospective study of SCD patient records. The
sample studied included all the patients admitted to a
public university hospital over a five-year period (2000–
2004) as a result of acute events related to SCD. The hos-
pital, located in Rio de Janeiro City in south-east Brazil,
forms part of the national health system (Sistema Único de
Saúde) and is a reference centre for the treatment of ado-
lescents and adults with SCD. Patient records were identi-
fied by the diagnoses that appear in the hospital's
electronic records. The patient records selected were those
bearing D57 codes (sickle cell disease), according to the
International Classification of Diseases – Tenth Revision.
After examining the records, those of patients not admit-
ted during the study period or with sickle-cell trait were
excluded. All non-elective admissions for acute events, in
which patients remained in the hospital for at least 24
hours, were included. Patients who died during the first
hospitalisation were excluded. A form and an instruction
manual were developed to guide extraction of informa-
tion on the patients and their admissions from the patient
records. All readmissions of each patient were considered
for analysis, regardless of the time elapsed between them.
Time to readmission or to censoring by death or end of
the observation period was modeled considering demo-
graphic and clinical covariates. Demographic covariates
included were age, gender, ethnicity and education. The
following independent clinical covariates were evaluated:
age, phenotype, vaso-occlusive crisis, acute thoracic syn-
drome, bacterial infection, chronic renal failure (CRF),
length of hospital stay (in days), use of opiates and
number of packed red blood cell transfusions. The clinical
covariates were selected on the basis of clinical criteria
considered relevant in SCD patient admissions.
The statistical approach was based on extensions of Cox's
proportional hazard model. Two models were fitted, one
marginal and the other conditional or of random effects
[11]. The Cox survival model is defined as a semi-para-
metric model because the baseline hazard function is
treated non-parametrically, not assuming any specific
probability distribution, while a parametric form is
assumed for the covariate effects. It is also called a propor-
tional hazards model as the ratio of hazard rates of any
two individuals is proportional and constant over time.
However, when an individual can experience multiple
events, the dependency between events within individual
has to be taken into account, and extensions of this model
have been proposed.
Among the various options, the Andersen-Gill (AG)
model, also known as the independent increment model
was chosen. Independence here means that each event –
"event" being each patient's hospital admissions – is not
conditioned by previous ones, i.e. by previous admis-
sions. That is, after each admission has occurred, the risk
of admission returns to the prior situation, depending
only on the characteristics of the individuals involved.
The events share the same covariates, but are independent
of one another.
Mathematically, the definition of the AG model is similar
to the classic Cox proportional hazard model:
where Hit indicates whether the subject i is at the time t at
observation and/or risk (= 1) or not (= 0), λo(t) is an arbi-
trary baseline hazard rate which remains unspecified, β is
the vector of parameters associate to the x vector of covari-
ates. The main difference between this model and the clas-
sical Cox model is the construction of the risk set –
individuals at risk in each observed time – and the estima-
tion of robust standard errors in the presence of repeated
events. In the AG model, as soon as the observed event
ends, the individuals is back to the same "at risk" situa-
tion.
Another approach to deal with multiple events is via ran-
dom effects models. Suppose a random variable zi repre-
senting an unknown random effect, related to each
patient, with unit mean and variance εi. Large values of εi
reflect a greater degree of heterogeneity among patients.
The form often assumed for the hazard rate is
λλ it i it i Ht () ( ) e x p ( )
, xx = 0 β β
λλ it i i i it i Ht ( ) ( ) ( )exp( )
, zx z x = 0 β βBMC Blood Disorders 2009, 9:2 http://www.biomedcentral.com/1471-2326/9/2
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The model holds two standard assumptions: (i) observa-
tions within each patient share a common frailty effect
over time, (ii) conditional on an chosen parametric distri-
bution – in this case a gamma distribution – the times to
events are assumed to be independent.
The intra-individual correlation is thus corrected, and by
means of this random effect, a set of unmeasured individ-
ual characteristics, which could be described as an indi-
vidual "frailty", is estimated. Here, differently from the
marginal models, the point estimate can be substantially
altered, depending on the magnitude of this random
effect.
Schoenfeld residuals were used to evaluate the assump-
tions of proportionality [12]. The explanatory power of
the models was estimated using an R2 indicator, calcu-
lated as 1 minus double the likelihood ratio between zero
and the proposed model [11]. All the models were fitted
using R software and the "survival" library [13].
The study was approved by the Research Ethics Commit-
tee of the National School of Public Health, Oswaldo
Cruz Foundation (Rio de Janeiro).
Results
From 2000 to 2004, the hospital treated 108 patients with
sickle cell disease, of whom 78 were hospitalised at least
once. Seven patients died during their first hospitalisation
and for that reason were excluded. The remaining 71
patients underwent 223 hospitalisations, of which 88.0%
(196) were readmissions, for treatment of SCD-related
acute events. The sample mean age was 20.2 years (13–
53). Most patients (85.9%) were admitted up to five times
during the study period, 5 were admitted 10 or more
times, and 1 patient was admitted 20 times. The median
of admissions was 2.0 (1–20) and the most frequent cause
was vaso-occlusive crisis (73.1%). The patients' character-
istics are shown in Table 1.
Table 2 shows the hazard ratios for hospital readmission,
by characteristics of the patients and admissions, in two
survival models. On both the AG and frailty models, the
occurrence of vaso-occlusive crisis (VOC) in a prior
admission associated significantly with time elapsed to
the following admission. Likewise, in both models,
chronic renal failure (CRF) associated significantly with
time between admissions, although the greater risk was
encountered on the frailty model (RR = 27.25 CI 5.11-
145.43). None of the demographic characteristics were
associated with time to readmission either on the AG or
on the frailty models.
The models' explanatory power evaluated by the R2 meas-
ure, was 0.25 for the AG model and 0.60 for the frailty
model, indicating a better fit by the latter, where the vari-
ance of the random effects was 0.85. In the frailty model,
3 patients were outliers, with excessively high hazard for
hospital readmissions (data not shown).
The analysis of Schoenfeld residuals indicated serious lim-
itations of the AG model. Covariates such as age, number
of packed red blood cell transfusions and length of hospi-
tal stay on previous admission, although not significantly
associated with risk of a further admission, presented lin-
ear correlation with time, suggesting that this model does
not comply with the proportion hazard assumption.
Discussion
It is important to identify what type of variable (demo-
graphic, genetic or clinical) and what variables are associ-
ated with the risk of hospital admission in patients with
SCD, because some of them will undergo multiple hospi-
talisations in the course of their lives. The assumption of
independence of hospital admissions means that after
being discharged from hospital the patient returns to the
baseline risk of a further hospitalization occurring. The
Table 1: Distribution of patients characteristics and hospital 
admissions in patients with SCD admitted to a public university 
hospital, southeastern Brazil, 2000–2004
Patients Characteristics Frequency (%)
N = 71
Sex
Male 36 (50,7)
Female 35 (49,3)
Phenotype
SS 57 (80,3)
Others 14 (19,7)
Ethnicity
White 14 (19,7)
Non-white 57 (80,3)
Education
Elementary school 41 (57,7)
Other 30 (42,3)
Hospital admissions
N = 223
Vaso-occlusive crisis 163 (73,1)
Acute chest syndrome 17 (7,6)
Bacterial infection 64 (28,7)
Chronic renal failure 11 (4,9)
Opiate use 188 (84,3)BMC Blood Disorders 2009, 9:2 http://www.biomedcentral.com/1471-2326/9/2
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reasoning that sustains this hypothesis is the acute charac-
teristic of the events, that do not result in sequelae (at
least, not "measurable" ones), and therefore are resolved
during the hospital stay. In such a setting, the AG inde-
pendent increment model is reasonably adequate.
Although the occurrence of successive VOCs causes
chronic organ damage, such damage is slow to appear.
That is why it is plausible to think, in studies with rela-
tively short observation periods, that VOC behaves as an
independent event at each readmission. As regards CRF,
on the AG model, the estimates point to a significant asso-
ciation with time elapsed until readmission, and the haz-
ard ratio is high. CRF is a difficult condition to
compensate for, and is often associated with non-SCD-
related complications that require hospital treatment. In
addition, CRF associates with premature death in patients
with SCD.
A number of prognostic factors for the occurrence of unfa-
vourable outcomes and serious conditions from SCD
have been described [14]. Foetal haemoglobin, the coex-
istence of thalassaemia and haplotypes have been studied
much more as risk factors modulating these clinical out-
comes, as have various genetic polymorphisms described
recently [15]. The unfavourable outcomes generally
require hospital treatment and it is possible that they
influence the number of admissions and the time inter-
vals between them, given that the frequency of hospitali-
sation also associates with worse prognosis and increased
risk of death [6,7,16]. Presentation in multiple pheno-
types – i.e. the great variability within SCD, a monogenic
disease – is probably due to genetic factors that have not
yet been completely studied.
In this context, the frailty model offers the advantage of
improving the estimation of parameters and related
Table 2: Comparison between survival models in hospital readmissions in patients with SCD admitted to a public university hospital, 
southeastern Brazil, 2000–2004
Clinical characteristics
AG model Frailty Model
HR 95% CI HR 95% CI
Age 0.99 0.96–1.02 0.98 0.94–1.01
Phenotype
Others 1.00 1.00
SS 1.60 0.92–2.77 1.96 0.88–4.37
Vaso-occlusive crisis
No 1.00 1.00
Yes 2.06 1.23–3.45 2.14 1.19–3.87
Acute chest syndrome
No 1.00 1.00
Yes 1.30 0.54–3.11 1.23 0.56–2.73
Bacterial infection
No 1.00 1.00
Yes 0.90 0.54–1.51 0.89 0.51–1.53
Chronic renal failure
No 1.00 1.00
Yes 22.17 10.13–48.54 27.25 5.11–145.43
Opiates
No 1.00 1.00
Yes 1.32 0.62–2.84 0.70 0.33–1.46
Number of red cell concentrate transfusions 1.04 0.86–1.26 1.03 0.87–1.23
Length of hospital stay (days) 0.99 0.96–1.02 1.00 0.96–1.03
Frailty Variance 0.85 p = 0.00000
AG = Andersen-Gill; HR = hazard ratioBMC Blood Disorders 2009, 9:2 http://www.biomedcentral.com/1471-2326/9/2
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standard errors, even in the absence of important covari-
ates, as it contemplates the role of unmeasured variables,
such as genetic factors. In the frailty model, the VOC and
CRF variables remain significant, despite the large confi-
dence interval. The hazard ratio for CRF was also very
high, as in the AG model. The highest R2 was observed in
the frailty model (0.60), corroborating the importance of
unmeasured factors. As yet undetermined genetic aspects,
such as polymorphisms, may account for this great varia-
bility.
Other approaches were also considered, such as the Pren-
tice, Williams and Peterson (PWP) model, in which each
event belongs to a different, ordered stratum (first hospi-
talization, second hospitalization, and so on). Using
time-dependent strata means that, unlike the AG model
(where the likelihood of any event is the same), the
underlying intensity function can vary from event to
event. SCD is hereditary and its clinical manifestations
occur from birth. Therefore, in order to fit a PWP model,
it would be necessary to number and order each hospital-
isation, which would require hospital records for a
patient's whole life, which is beyond the scope of this
study.
In the frailty model three patients displayed excess hazard
significantly greater than 1, suggesting that in these cases
the individuals had other characteristics which would
explain the times to hospital readmissions. The three
patients were young females. The patient with greatest rel-
ative hazard in the frailty model was the one most hospi-
talised in the period and, among all the patients in the
hospital, the only one diagnosed as dependent on mor-
phine, an opiate used to control pain in patients with
SCD. Morphine dependence, although rare in the study
sample, was certainly decisive in the pattern of hospitali-
sation, because it is a condition that causes greater need
for the drug, leading the patient to seek hospital care more
often. It is important to look for signs of opiate depend-
ence, which should be treated promptly by appropriately
trained personnel.
In this study, the models did not include others patients'
socio-economic variables which might be associated with
hospital re-admission, for lack of such information in the
patient records. This is a limitation on the study, because
it is reasonable to suppose that the patients' social profile
would influence the pattern of hospitalisation. For exam-
ple, some patients may face financial difficulties in pur-
chasing drugs and thus seek hospital care more often,
even when the pain could be controlled at home.
Conclusion
In this study, we observed that the semi-parametric mod-
elling of proportional hazard ratio was appropriate to
studying multiple hospitalisations in patients with SCD.
The fit of the AG model displayed limitations. The high R2
encountered in the frailty model suggests that factors not
included in the modelling were important in the hazard
of hospital readmission.
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